Publications by authors named "Peter Meldgaard"

Claim this Profile
C
Clinical and molecular characteristics of 42 Danish patients with metastatic ALK fusion-positive lung cancer treated with first-line alectinib: A nationwide study.
Maiken Parm Ulhøi, Emma Roger Andersen, Christoffer Trier Maansson, Lars Munch Larsen, Miroslaw Stelmach, Peter Meldgaard

Cancer Treat Res Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal investigation of sleep and circadian rest-activity rhythms in non-small cell lung cancer patients during immunotherapy and associations with fatigue, depression, and perceived stress.
Louise Strøm, Robert Zachariae, Lisa M Wu, Peter Meldgaard, Sonia Ancoli-Israel

Sleep Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma extrachromosomal circular DNA as a biomarker in EGFR-targeted therapy of non-small cell lung cancer.
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta

Mol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Navigating treatment sequencing in ALK-positive non-small cell lung cancer: lorlatinib as a key to prolonged survival?
Maiken Parm Ulhøi, Peter Meldgaard

Transl Lung Cancer Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA can detect minimal residual disease in curative treated non-small cell lung cancer patients using a tumor agnostic approach.
Lærke Rosenlund, Kasper Guldbrandsen, Lise Barlebo Ahlborn, Martin Bloch, Kristin Skougaard, Peter Meldgaard

Lung Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of an LC-MS/MS method for quantification of Osimertinib and its two metabolites AZ7550 and AZ5104 in human plasma including long-time storage.
Eva Greibe, Boe Sorensen, Peter Meldgaard, Elke Hoffmann-Lücke

J Pharm Biomed Anal· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.
Maise Al Bakir, James L Reading, Samuel Gamble, Rachel Rosenthal, Imran Uddin, Peter Meldgaard

Nature· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of multidisciplinary team discrepancies on comparative lung cancer outcome analyses and treatment equality.
Torben Riis Rasmussen, Anja Gouliaev, Erik Jakobsen, Karin Hjorthaug, Lene Unmack Larsen, Peter Meldgaard

BMC Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Venous Thromboembolism in Patients With Stage III and IV Non-Small-Cell Lung Cancer: Nationwide Descriptive Cohort Study.
Anne Gulbech Ording, Thomas Decker Christensen, Flemming Skjøth, Simon Noble, Anette Arbjerg Højen, Peter Meldgaard

Clin Lung Cancer· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
size-selection of short circulating tumor DNA fragments from late-stage lung cancer patients enhance the detection of mutations and aneuploidies.
Christoffer Trier Maansson, Louise Skov Thomsen, Laura Stokkebro, Julie Gabe Dissing, Maiken Parm Ulhoi, Peter Meldgaard

J Liq Biopsy· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
ctDNA-based minimal residual disease detection in lung cancer patients treated with curative intended chemoradiotherapy using a clinically transferable approach.
Lærke Rosenlund Nielsen, Simone Stensgaard, Peter Meldgaard, Boe Sandahl Sorensen

Cancer Treat Res Commun· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In-hospital thromboprophylaxis variation and the risk of venous thromboembolism after lung cancer surgery: a nationwide cohort study.
Thomas Decker Christensen, Anne Gulbech Ording, Flemming Skjøth, Amalie Lambert Mørkved, Erik Jakobsen, Peter Meldgaard

Interdiscip Cardiovasc Thorac Surg· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lung cancer patients with anaplastic lymphoma kinase rearrangement lose affiliation with labor market at diagnosis.
Jon Lykkegaard Andersen, Jakob Sidenius Johansen, Edyta Maria Urbanska, Peter Meldgaard, Peter Hjorth-Hansen

Lung Cancer Manag· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes.
Theresa May, Michelle S Clement, Harkanwal Halait, Alexander Kohlmann, Milena Kohlmann, Peter Meldgaard

PLoS One· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic accuracy of the geriatric screening tools G8 and modified G8 in older patients with lung cancer: A diagnostic performance study.
Danny Bech, Lone Winther Lietzen, Peter Meldgaard, Anne-Kathrine Ryltoft, Marianne Ørum

J Geriatr Oncol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk and Timing of Venous Thromboembolism After Surgery for Lung Cancer: A Nationwide Cohort Study.
Amalie Lambert Mørkved, Mette Søgaard, Flemming Skjøth, Anne Gulbech Ording, Martin Jensen, Peter Meldgaard

Ann Thorac Surg· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancer.
Torben Steiniche, Jeanette Baehr Georgsen, Peter Meldgaard, Anne C Deitz, Mark Ayers

Front Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of Cell-Free DNA End Motifs and Fragment Lengths Can Identify Active Genes in Liquid Biopsies.
Christoffer Trier Maansson, Louise Skov Thomsen, Peter Meldgaard, Anders Lade Nielsen, Boe Sandahl Sorensen

Int J Mol Sci· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved overall survival for Stage III NSCLC patients treated with curative-intended therapy from 2010 to 2018-a cohort study in Denmark.
Peter Meldgaard, Michael Kristensen, Simona Conte, Klaus Kaae Andersen, Aleksander Jovanovic, Ebbe Meldgaard

Acta Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes of + non-small cell lung cancer in Denmark.
Karin Holmskov Hansen, Jakob Sidenius Johansen, Edyta Maria Urbanska, Peter Meldgaard, Peter Hjorth-Hansen

Acta Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can liquid biopsy dynamics stratify patients with small cell lung cancer?
Christoffer T Maansson, Peter Meldgaard, Boe Sandahl Sorensen

Transl Lung Cancer Res· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma Immune Proteins and Circulating Tumor DNA Predict the Clinical Outcome for Non-Small-Cell Lung Cancer Treated with an Immune Checkpoint Inhibitor.
Simone Stensgaard, Astrid Thomsen, Sofie Helstrup, Peter Meldgaard, Boe S Sorensen

Cancers (Basel)· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic Workup, Treatment Patterns, and Clinical Outcomes in Early-Stage IB-IIIA Non-Small-Cell Lung Cancer Patients in Denmark.
Ebbe Meldgaard Uldbjerg, Lars Ringgaard, Klaus Kaae Andersen, Line Elmerdahl Frederiksen, Aleksandar Jovanovic, Peter Meldgaard

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer.
Simone Stensgaard, Astrid Thomsen, Sofie Helstrup, Peter Meldgaard, Boe S Sorensen

Transl Lung Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNAfusion: an R/Bioconductor package for increased sensitivity of detecting gene fusions in liquid biopsies.
Christoffer Trier Maansson, Emma Roger Andersen, Maiken Parm Ulhoi, Peter Meldgaard, Boe Sandahl Sorensen

BMC Bioinformatics· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis